Loren Danzis, Jeffrey Nicholas and Elizabeth Sigety To Receive PA Biotechnology Center Entrepreneur Champion Award

Philadelphia – July 1, 2015 – Fox Rothschild LLP is pleased to announce that corporate partners Loren Danzis, Jeffrey Nicholas and Elizabeth Sigety have been selected as recipients of the Pennsylvania Biotechnology Center Entrepreneur Champion Award. They will be honored at the Biotech Barons Awards and Networking Reception on July 16.

The award was created by the Biotechnology Center to recognize those who have made extraordinary and notable beneficial contributions to the advancement of entrepreneurship in the region. Danzis, Nicholas and Sigety are being recognized for founding and managing the Delaware Crossing Investor Group, a network of angel investors operating in the Philadelphia and Princeton region. Delaware Crossing provides counsel and capital to early stage and growth oriented companies – contributing a wide array of industry expertise and support to entrepreneurs in this region. Since 2005, Delaware Crossing has invested approximately $7 million in early stage companies.

Danzis serves on the Board of Directors of the Hepatitis B Foundation and as co-chair of firm’s Life Sciences Practice Group. He counsels clients in the fields of biotechnology, pharmaceuticals, life sciences, information technology and computer software and has particular experience in venture capital transactions, acquisitions and commercial contract negotiations. For 14 years, he has represented companies seeking capital and the investors who provide it. Danzis also represents both public and private companies on mergers and acquisitions and advises on strategic alliances, licensing, distribution and strategic agreements and executive compensation.

Nicholas, who chairs the firm’s nationwide Corporate Department and serves as managing partner of the firm’s Bucks County office, represents clients in a wide variety of corporate and commercial matters, including mergers and acquisitions of public and private companies; private equity transactions; seed, angel and venture capital financings; securities reporting and disclosure; securities offerings and transactions; corporate governance; Special Committee and Audit Committee representation; and executive compensation matters. Nicholas serves biotechnology, pharmaceutical, life science and technology clients as general counsel, combining the broad legal experience and practical business knowledge of an effective business adviser.

As co-chair of the firm’s Emerging Companies Practice Group, Sigety acts as general counsel for numerous emerging and middle-market businesses, including life science and technology companies, overseeing and coordinating their corporate, venture finance and regulatory matters. For 25 years, Sigety has been a trusted adviser to startup companies and entrepreneurs, handling business and financial transactions such as venture capital and angel financing, mergers and acquisitions, franchising, securities, private placements, franchise regulatory matters and franchise agreements.

About the Pennsylvania Biotechnology Center of Bucks County
The Pennsylvania Biotechnology Center of Bucks County offers state-of-the-art laboratory and office space to nonprofit research companies and biotech companies. Created by a partnership between the Hepatitis B Foundation and Delaware Valley College, and managed by the Blumberg Institute, the Center was funded in part by the Commonwealth of Pennsylvania. The facility opened in 2006 in a formerly abandoned warehouse and has since grown to encompass 110,000 square feet on a 10-acre campus. To learn more, visit www.pabiotechbc.org.

About Fox Rothschild LLP
Fox Rothschild LLP (www.foxrothschild.com) is an AmLaw 100 full-service law firm built to serve businesses of all sizes as well as individuals. Over the past 100 years, we have grown to nearly 650 lawyers in 21 offices coast to coast. Fox’s team of emerging company attorneys helps position companies – including seed, early and emerging growth – as well as their investors and business leaders for growth, expansion, commercialization, partnership and exit. We have extensive experience representing technology, life science, health care and clean technology companies and the investors who fund them. Combining legal knowledge, IP strategy and financial acumen, we leverage our in-depth industry experience to bring the right people and deals together.

©2020 PACT All Rights Reserved